Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Koninklijke Philips Electronics ADR (NY: PHG )

27.01 +0.62 (+2.35%)
Streaming Delayed Price Updated: 11:57 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Koninklijke Philips Electronics ADR

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Philips successfully prices offering of Notes for EUR 500 million to be used for repayment of existing debt, resulting in a debt-neutral effect
From Royal Philips
Via GlobeNewswire
Philips integrates AI in cardiac ultrasound and across cardiac care at ESC 2023
From Royal Philips
Via GlobeNewswire
EXCLUSIVE: ProSomnus' Device Therapy Better Than Philip's Device(s) For Sleep-Related Breathing Disorder, Study Shows
ProSomnus Inc (NASDAQ: OSA), a provider of CPAP alternatives for Obstructive Sleep Apnea, announced updated data presented at the ProSleep Conference earlier this month.  The updated data indicate the... 
Via Benzinga
Why Shares in Philips Soared This Week
The medical technology company welcomed a very high-profile investor this week. 
Via The Motley Fool
Why Philips Shares Are Surging Today
Koninklijke Philips NV (NYSE: PHG) shares are trading higher by around 5% after Exor N.V. bought  
Via Benzinga
Philips Says Test Results Show Recalled Sleep Devices Unlikely To Cause Harm
Via Benzinga
First Solar's Internal Audit Reveals Instances Of Forced Labor, Philips Recalls Faulty Ventilators, Home Depot's Q2 Performance: Today's Top Stories
Benzinga Home Depot's Q2 Performance: Revenue Dip, New Stock Buyback And More 
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Philips Recalls Faulty Ventilators, FDA Identifies Dust Issue As 'Most Serious'
Koninklijke Philips N.V. (NYSE: PHG) is recalling several ventilators after detecting dust and dirt from the environment in the air path 
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Exor becomes a long-term investor in Philips supporting the company’s strategy
From Royal Philips
Via GlobeNewswire
The 7 Best Momentum Stocks to Buy in August
While many stocks have started to plateau recently, these momentum stocks still have the potential to run much higher from here. 
Via InvestorPlace
ResMed's Q4 Results: Analysts Say Uncertain Market Dynamics Follow Amid Philips Re-Entry
ResMed Inc (NYSE: RMD) posted Q4 adjusted EPS of $1.60, up from $1.49 a year ago, missing the consensus of $1.67. 
Via Benzinga
Philips Named to the Forbes Best Employers for Women 2023 List
From Royal Philips
Via Business Wire
Tesla's India Move, Adidas Receives Orders For Massive Unsold Yeezy Inventory, Spotify Raises Subscription Prices: Today's Top Stories
Wall Street Journal 
Via Benzinga
What's Going On With Philips Stock Monday?
Koninklijke Philips N.V.  (NYSE: PHG) stock is trading lower Monday after it reported a second-quarter comparable sales growth of 9% year-on-year to €4.47 billion ($4.87 billion), driven by growth... 
Via Benzinga
Philips delivers improved operational performance driven by sales growth and focus on execution
From Royal Philips
Via GlobeNewswire
Sell These 3 Blue-Chip Stocks Immediately
Although large-scale enterprises tend to offer smart investments, these are the blue-chip stocks to sell amid rising pressures. 
Via InvestorPlace
GE HealthCare's Solid Demand And Sensible Margin Targets: Morgan Stanley Sees Potential Upside Despite Street's High Expectations
Morgan Stanley analyst Patrick Wood initiated coverage on GE HealthCare Technologies Inc (NASDAQ: GEHC) with an Equal-Weight rating and a  
Via Benzinga
FDA Issues Warning Letter To iRhythm: An Opportunity For The Cardiac Monitoring Space And One Company In Particular?
The Food and Drug Administration (FDA) has issued a warning to the heart monitoring company iRhythm (NASDAQ: IRTC), stating that its products include viol 
Via Benzinga
IMAGIO consortium receives Innovative Health Initiative EUR 24 million grant to improve cancer treatments
From Royal Philips
Via GlobeNewswire
Philips to repurchase up to 7.1 million shares to cover long-term incentive plans
From Royal Philips
Via GlobeNewswire
Philips' direct-to-angio stroke pathway: new analysis demonstrates substantial cost savings in addition to improved patient outcomes
From Royal Philips
Via GlobeNewswire
Philips and Masimo introduce new, advanced monitoring capabilities to Philips high acuity patient monitors
From Royal Philips
Via GlobeNewswire
Philips and Vanderbilt University Medical Center unite to define roadmap for decarbonizing radiology
From Royal Philips
Via GlobeNewswire
Philips announces exchange ratio for 2022 dividend
From Royal Philips
Via GlobeNewswire
Philips launches AI-powered CT system to accelerate routine radiology and high-volume screening programs
From Royal Philips
Via GlobeNewswire
Former SVB CEO Blames Fed & Media Hype For Collapse, FTC Plans Lawsuit to Block Horizon Therapeutics $28B Takeover, Home Depot Lowers Annual Outlook: Today's Top Stories
Benzinga Former SVB Chief Blames Fed, Media Hype For Bank's Devastating Collapse 
Via Benzinga
Philips’ image-guided navigation increases safety during coronary interventions and reduces the use of contrast media by an average of 28.8%
From Royal Philips
Via GlobeNewswire
Philips provides update on completed set of test results for CPAP/BiPAP sleep therapy devices
From Royal Philips
Via GlobeNewswire
Philips Foundation 2022 Annual Report: partnering to provide healthcare access to over 26 million people in underserved communities
From Royal Philips
Via GlobeNewswire
Philips To Pay $62M Settlement On Corruption Charges In China
Dutch medical device maker Koninklijke Philips N.V. (NYSE: PHG) will pay $62 million to resolve charges that i 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.